How blind can 'read' shown in new research

May 16, 2012 in Medical research

How blind can 'read' shown in Hebrew University research

Enlarge

This is Ella Striem-Amit of the Hebrew University of Jerusalem. Credit: The Hebrew University of Jerusalem

A method developed at the Hebrew University of Jerusalem for training blind persons to "see" through the use of a sensory substitution device (SSD) has enabled those using the system to actually "read" an eye chart with letter sizes smaller than those used in determining the international standard for blindness.

The eight congenitally blind participants in the Hebrew University test group passed the conventional eye-exam of the Snellen acuity test, technically surpassing the world-agreed criterion of the World Health Organization (WHO) for blindness and moving them to the level of (low-vision) sighted. These results were published recently in the Journal in the US.

The Snellen test is a standard visual test in which the patient views a chart which contains the letter E facing four different directions and in various sizes. The patient sits at a specific distance of 20 feet (6 meters) and has to determine the direction of the E's, and according to the smallest size he can read, his visual acuity is determined.

Normal vision is considered 20/20, referring to both the distance and size of the symbols on the . The congenitally blind participants in the Hebrew University test group reached a median level of 20/360, meaning they could identify letters from a distance of 20 feet that a normally sighted person (with normal vision) would be able to identify from 360 feet. The 20/360 result is better than the World health organization criterion for blindness, which is 20/400.

The Hebrew University researchers -- Dr. Amir Amedi, of the Edmond and Lily Safra Center for Brain Sciences and the Institute for Medical Research Israel-Canada at the Hebrew University, and Ph.D. student Ella Striem-Amit -- have been using a sensory substitution device developed by Dr. Peter Meijer of Holland and called "The vOICe." The device converts images from a into "soundscapes," using a predictable algorithm, allowing the user to listen to and then interpret the visual information coming from the camera.

Remarkably, proficient users who have had a dedicated (but relatively brief) training at Dr. Amedi's lab were able to use SSDs to identify complex everyday objects, locate people and their postures, read letters and words, and even identify facial expressions.

Recently, the ability to extract and "translate" fine visual detail in this manner was demonstrated in an experiment led by Striem-Amit in which, for the first time, congenitally blind vOICe users were subjected to an ophthalmologist's standard visual acuity test, using sounds. Surprisingly, not only were the blind SSD-users able to tell which way the "tumbling E's" were turning using sounds, but most of them could perform the test at small letter sizes, below the standard World Health Organization's blindness threshold.

Such visual capacities greatly surpass even those possible by the most advanced cutting-edge retinal prostheses ("bionic eyes") available today. In fact, even though retinal prostheses may improve their resolution in the future, and have the advantage of providing the sensation of sight, they will not be accessible to a large population of blind individuals. Retinal prostheses target only very specific blindness etiologies, leaving many others without medical cure.

This factor, as well as the invasiveness and high cost of retinal prostheses make non-invasive and very cheap SSDs, such as The vOICe or other novel SSDs developed in Amedi's lab, attractive alternatives, which can be available already today to the 39 million worldwide blind population, the majority of whom live in developing countries, who could already enjoy the adventure of learning to "see" in high resolution, using sound.

Journal reference: PLoS ONE search and more info website

Provided by Hebrew University of Jerusalem search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Study reveals new mechanism for estrogen suppression of liver lipid synthesis

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

Medical research created May 23, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

MRI-based measurement helps predict vascular disease in the brain

Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...

Medical research created May 23, 2013 | popularity not rated yet | comments 0

Antibiotics: A new understanding of sulfonamide nervous system side effects

Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...

Medical research created May 23, 2013 | popularity 3 / 5 (1) | comments 0 | with audio podcast

Scientists discover molecule triggers sensation of itch

Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...

Medical research created May 23, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Discarded immune cells induce the relocation of stem cells

Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...

Medical research created May 23, 2013 | popularity 5 / 5 (2) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.